Cat: IPD-X21565

Recombinant Mouse LAG-3 Protein(HEK293), hFc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    LAG-3

  • 简介

    LAG-3 (lymphocyte activation gene 3) protein is expressed on antigen-activated T cells and transmits inhibitory signals by binding to ligands such as FGL1.FGL1 is the main ligand responsible for the suppressive function of LAG3 T cells.LAG-3 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived LAG-3 protein, expressed by HEK293 , with C-hFc labeled tag.

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 生物活性

    1. Measured by its ability to bind FGL1 Protein, Mouse, Recombinant (His Tag) in functional ELISA. 2. Immobilized Mouse LAG-3, hFc Tag at 5 μg/mL (100 μL/well) can bind Mouse FGL1 (HY-P75189). The ED50 for this effect is 0.1192 μg/mL, corresponding to a specific activity is 8.39×10^3 Unit/mg. Immobilized Mouse LAG-3, hFc Tag at 5 μg/mL (100 μL/well) can bind Mouse FGL1 (HY-P75189). The ED50 for this effect is 0.1192 μg/mL, corresponding to a specific activity is 8.39×103 Unit/mg.

  • 别名

    Lymphocyte activation gene 3 protein; Protein FDC; CD223

  • 种属

    Mouse

  • 表达系统

    HEK293

  • 标签

    C-hFc

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q61790

  • 表达区间

    S23-L442

  • 氨基酸序列

    SGPGKELPVVWAQEGAPVHLPCSLKSPNLDPNFLRRGGVIWQHQPDSGQPTPIPALDLHQGMPSPRQPAPGRYTVLSVAPGGLRSGRQPLHPHVQLEERGLQRGDFSLWLRPALRTDAGEYHATVRLPNRALSCSLRLRVGQASMIASPSGVLKLSDWVLLNCSFSRPDRPVSVHWFQGQNRVPVYNSPRHFLAETFLLLPQVSPLDSGTWGCVLTYRDGFNVSITYNLKVLGLEPVAPLTVYAAEGSRVELPCHLPPGVGTPSLLIAKWTPPGGGPELPVAGKSGNFTLHLEAVGLAQAGTYTCSIHLQGQQLNATVTLAVITVTPKSFGLPGSRGKLLCEVTPASGKERFVWRPLNNLSRSCPGPVLEIQEARLLAERWQCQLYEGQRLLGATVYAAESSSGAHSARRISGDLKGGHL

  • 蛋白长度

    Partial

  • 分子量

    82-96 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

LAG-3 (Lymphocyte Activation Gene-3) is an immune checkpoint receptor that plays a significant role in regulating T cell activity and maintaining immune homeostasis. It is highly expressed on activated T cells, regulatory T cells, and certain other immune cells. In cancer immunotherapy, LAG-3 has garnered considerable attention due to its ability to inhibit T cell function, making it a potential target for enhancing anti-tumor immunity. Research has shown that LAG-3 interacts with MHC class II molecules, leading to a downregulation of T cell activation and proliferation. Understanding the molecular mechanisms underlying LAG-3 signaling and its role in immune escape by tumors has become a critical focus. Additionally, the development of LAG-3-targeted therapies, including monoclonal antibodies and recombinant proteins, is being explored to improve the efficacy of existing immunotherapeutic approaches. These studies aim not only to block LAG-3’s inhibitory effects but also to use LAG-3 as a biomarker for patient stratification in immunotherapy. The exploration of LAG-3 recombinant proteins has attracted interest as tools for both studying its biology and advancing therapeutic strategies, particularly in combination with other immune modulators. Overall, ongoing research on LAG-3 continues to shed light on its dual role in immune regulation and its potential as a therapeutic target in various diseases, including cancer and autoimmune disorders.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US